VEGF(165) and bFGF protein-based therapy in a slow release system to improve angiogenesis in a bioartificial dermal substitute in vitro and in vivo.

Source:http://linkedlifedata.com/resource/pubmed/id/17404752

Download in:

View as

General Info

PMID
17404752